Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA grants orphan drug designation to tarextumab in pancreatic and small-cell lung cancer

Jan. 30, 2015

New data on the efficacy and safety of MM-141 in combination therapy

Jan. 30, 2015

Advaxis reports update on phase II study of ADXS-HPV

Jan. 29, 2015

FDA clears IND for phase I study of ADXS-HER2

Jan. 23, 2015

Phase I/II results of isactuzumab govitecan in gastrointestinal cancer patients

Jan. 22, 2015

BioInvent's BI-1206 to enter collaborative phase I/II trial

Jan. 21, 2015

Safety and dosing data presented for a novel gastric cancer vaccine

Jan. 19, 2015

OncoMed enrolls first biomarker-selected patient in anti-Notch 1 expansion trial

Jan. 16, 2015

Promising results presented for chimeric antigen receptors in B-cell cancer treatment

Jan. 15, 2015

Precision Biologics discloses interim survival data for NPC-1C in metastatic colorectal cancer

Jan. 15, 2015

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...